The study of the inhibition of the recombinant TACE prodomain to endotoxemia in mice

International Journal of Molecular Sciences

Volumn 10, Issue 12, 2009, Pages 5442-5454

  Li, Xiaoou ^a   Yan, Yuan ^b   Huang, Wei ^b   Yang, Yuzhen ^b  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Inhibitor; Prodomain; TACE; TNF

Indexed keywords

COMPLEMENTARY DNA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; EXPERIMENTAL MODEL; FEMALE; GENE AMPLIFICATION; GENETIC CODE; HISTOPATHOLOGY; INFLAMMATION; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PROTEIN DOMAIN; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

INHIBITOR; PRODOMAIN; TACE; TNF-Α;

ADAM PROTEINS; ANIMALS; ENDOTOXEMIA; ENZYME INHIBITORS; FEMALE; MICE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 74249111726     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10125442     Document Type: Article

References (32)

1. Stone, A.L.; Kroeger, M.; Sang, Q.X. Structure-function analysis of the ADAM family of disintegrin-like an metalloproteinase-containing protein. J. Protein Chem. 1999, 18, 447-465.
2. Wolfsberg, T.G.; Peimakoff, P.; Myles, D.G.; White, J.M. ADAM, a novel family of membrane protein containing a disintegrin and metalloprotease domain. Cell Biol. 1995, 131, 275-278.
3. Schlondorff, J.; Blobel C.P. Metalloprotease-disintegrins: Modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J. Cell Sci. 1999, 112, 3603-3617.
4. Kang, T.; Zhao, Y.G.; Pei, Q.; Sucic, J.F.; Sang, Q.X. Intracellular activation of human ADAM19 by furin occurs via one of the two consecutive recognitions sites. Eur. J. Biochem. 2003, 270, 2386-2393.
5. Galazka, G.; Windsor, L.J.; Birkedal-Hansa, H. APMA (4-Aminophenylmercu acetate) activation of stromelysin-1 involves protein interactions in addition to those with cystine-75 in the propeptider. Biochemistry 1999, 8, 316-1322.
6. Nakayama, K. Furin: A mammaliam subtilisin / kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 1997, 327, 625-635.
7. Anders, A.; Gilbart, S.; Garten, W.; Postina, R.; Fahrennolz, H. Regulation of the α-secretase ADAM10 by its prodomain and proprotein convertase. FASEB J. 2001, 5, 1837-1839.
8. Kang, T.; Zhao, Y.G.; Pei, D; Sucic, J.F.; Sang, Q.X. Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J. Biol. Chem. 2002, 77, 25583-25591.
9. Loechel, F.; Gilpin, B.J.; Engvall, E.; Albrechtsen, R.; Wewer, U.M. Human ADAM 12 (meltrin) is an active metalloprotease. J. Biol. Chem. 1998, 273, 16993-16997.
10. Locksley, R.M.; Killeen, N.; Lenardo, M.J. The TNF and TNF receptor supurfamilies integrating mammalian biology. Cell 2001, 104, 487-501.
11. Stone, A.L.; Kroeqer, M.; Sang, Q.X Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing protein. Prot. Chem. 1999, 18, 447-465.
12. Wolfsberg, T.G.; Primakoff, P.; Myles, D.G.; White, J.M. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain. Cell Biol. 1995, 131, 275-278.
13. Black, R.A.; Rauch, C.T.; Kozlosky, C.J.; Peschon, J.J.; Slack, J.L.; Wolfson, M.F.; Castner, B.J.; Stocking, K.L.; Reddy, P.; Srinivasan, S.; Nelson, N.; Boiani, N.; Schooley, K.A.; Gerhart, M.; Davis, R.; Fitzner, J.N.; Johnson, R.S.; Paxton, R.J.; March, C.J.; Cerretti, D.P. A metalloproteinase disintegrin that releases tumor-necrosis factor-alapha from cells. Nature 1997, 385, 729-733.
14. Moss, M.L.; Jin, L.C.; Milla, M.E.; Burkhart, W.; Carter, H.L.; Chen, W.J.; Clay, W.C.; Didsbury, J.R.; Hassler, D.; Hoffman, C.R.; Kost, T.A.; Lambert, M.H.; Leesnitzer, M.A.; McCauley, P.; McGeehan, G.; Mitchell, J.; Moyer, M.; Pahel, G.; Rocque, W.; Overton, L.K.; Schoenen, F.; Seaton, T.; Su, J.L.; Becherer, J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-alpha. Nature 1997, 385, 733-736.
15. Philip, R.; Epstein, L. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 1986, 323, 86-89.
16. Heller, R.A; Kronke, M. Tumor necrosis factor receptormediated signaling pathways. J. Cell Biol. 1994, 126, 5-9.
17. Huang, W.; Li, L.B.; Huang, L.; Yang, Y.Z. Screening of TACE peptide inhibition from phage display peptide library. J. Huazhong Univ. Sci. Technol. 2005, 25, 473-476.
18. Ting, T.B.; Li, L.B.; Zhu, K.L.; Huang, W.; Yang, Y.Z. Relationship between the increase of secretion of sTNF-α induced by L ipopolysacchar ides and the enhanced expression of TACEmRNA in HL-60 cells and adhesive cells from human spleen. J. Tongji Med. Univ. 2001, 21, 265-268.
19. Loechel, F.; Overgaard, M.T.; Oxvig, G. Regulation of human ADAM12 protease by the prodomain. J. Biol. 1999, 274, 13427-13433.
20. Amin, A.R. Regulation of tumor necrosis factor-alpha and tumor necrosis factor-alpha converting enzyme in human osteoarthris. Osteoarthritis Cartilage 1999, 79, 392-394.
21. Moss, M.L.; Jin, S.L.; Milla, M.E.; Bickett, D.M.; Burkhart, W.; Carter, H.L.; Chen, W.J.; Clay, W.C.; Didsbury, J.R.; Hassler, D.; Hoffman, C.R.; Kost, T.A.; Lambert, M.H.; Leesnitzer, M.A.; McCauley, P.; McGeehan, G.; Mitchell, J.; Moyer, M.; Pahel, G.; Rocque, W.; Overton, L.K.; Schoenen, F.; Seaton, T.; Su, J.L.; Becherer, J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997, 385, 733-736.
22. Peschon, J.J.; Slecck, J.L.; Reddy, P. Enhanced: A cellular striptease act. Science 1998, 282, 1279-1280.
23. Zhu, K.L.; Yang, Y.Z.; Han, L. The study on different acting mechanisms of three types of TACE inhibitors in converting of pro-TNFα into sTNFα [in Chinese]. Chin J. Immunol. 2003, 19, 711-752;
24. Milla, M.E.; Leesnitzer, M.A.; Moss, M.L. Specific sequence elements are required for the expression of functional tumor. J. Biol. Chem. 1999, 274, 30563-30570.
25. Raetz, C.R.; Ulevitch, R.J.; Wright, S.D.; Sibley, C.H.; Ding, A.; Nathan, C.F. Gram-negative endotoxin. An extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991, 5, 2652-2660.
26. Ulevitch, R.J.; Tobias, P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 1995, 13, 437-457.
27. Pajkrt, D.; Doran, J.E.; Koster, F. Anti-inflammatory effects of reconstituted high-density lipoprotein during human endotoxaemia. J. Cell Biol. 1996, 184, 1601-1608.
28. Deitch, E.A. Role of bacterial translocation in necrotizing enterocolitis. Acta Paediatr. Suppl. 1994, 396, 33-36.
29. Nadler, E.P.; Upperman, J.S.; Dickinson, E.C.; Ford, H.R. Nitric oxide and intestinal barrier failure. Semin. Pediatr. Surg. 1999, 8, 148-154.
30. Choe, Y.H.; Lee, S.W. Effect of lactoferrin on the production of tumor necrosis factor-alpha and nitric oxide. J. Cell Biochem. 1999, 76, 30-36.
31. Sahin, U.; Weskamp, G.; Zhou, H.M.; Higashiyama, S.; Peschon, J.; Hartmann, D.; Saftig, P.; Blobel, C.P. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 2004, 164, 769-779.
32. NTR). J. Biol. Chem. 2004, 279, 4241-4249.